Stay updated on IMGN779 in CD33+ AML: Clinical Trial

Sign up to get notified when there's something new on the IMGN779 in CD33+ AML: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMGN779 in CD33+ AML: Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Updated revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' element; overall, this is a minor page update with no substantive content changes.
    Difference
    0.3%
    Check dated 2025-09-14T23:44:44.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-09-07T20:25:46.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to acute myeloid leukemia and various pathological conditions. However, several previous terms and specific diseases have been removed.
    Difference
    4%
    Check dated 2025-08-31T12:37:39.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    There are no significant changes to the web page content.
    Difference
    1%
    Check dated 2025-08-24T08:22:12.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    1%
    Check dated 2025-08-17T05:13:49.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.11, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-08-10T00:51:01.000Z thumbnail image

Stay in the know with updates to IMGN779 in CD33+ AML: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMGN779 in CD33+ AML: Clinical Trial page.